Search

Your search keyword '"Dilic, Mirza"' showing total 172 results

Search Constraints

Start Over You searched for: Author "Dilic, Mirza" Remove constraint Author: "Dilic, Mirza"
172 results on '"Dilic, Mirza"'

Search Results

1. Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

2. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the Editors´ Network

3. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

4. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

5. Incidence of cardiovascular events in patients with stabilized coronary heart disease : the EUROASPIRE IV follow-up study

7. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

11. Factors associated with use of percutaneous coronary intervention among elderly patients presenting with ST segment elevation acute myocardial infarction (STEMI): Results from the ISACS-TC registry

12. Fostering diffusion of scientific contents of National Society Cardiovascular Journals: The new ESC search engine

13. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

15. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries

16. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

17. Fostering diffusion of scientific contents of National Society Cardiovascular Journals: the new ESC search engine

18. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

19. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

20. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

21. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

22. Delayed Care and Mortality Among Women and Men With Myocardial Infarction

23. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

24. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

25. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

27. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report fromthe European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries.

28. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries

29. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors’ network

30. Data Sharing

33. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries

35. SEX-BASED DIFFERENCES IN SHORT TERM SURVIVAL AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION: THE ROLE OF SYSTEM DELAY

36. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.

37. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

38. Reperfusion therapy for ST-elevation acute myocardial infarction in Eastern Europe: the ISACS-TC registry

41. Fostering diffusion of scientific contents of National Society Cardiovascular Journals: The new ESC search engine

42. SEX-RELATED DIFFERENCES IN ACUTE CORONARY CARE AMONG PATIENTS WITH MYOCARDIAL INFARCTION: THE ROLE OF PRE-HOSPITAL DELAY

43. PARADOXICAL SEX DIFFERENCE IN IN-HOSPITAL OUTCOME FOLLOWING AN ACUTE CORONARY SYNDROME MANAGED CONSERVATIVELY: RESULTS FROM THE ISACS-TC

44. Exploring In-hospital Death from Myocardial Infarction in Eastern Europe: From the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC); on the Behalf of the Working Group on Coronary Pathophysiology & Microcirculation of the European Society of Cardiology

45. Veri Paylaşımı: Uluslararası Tıp Dergileri Editörleri Kurulu’ndan Yeni bir Editöryal Girişim Editör Ağı ile İlgili Öneriler.

46. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions

47. ROUTINE PERCUTANEOUS CORONARY INTERVENTION VERSUS MEDICAL THERAPY IN CLINICAL PRACTICE: THE ISACS-TC REGISTRY

Catalog

Books, media, physical & digital resources